Skip to main content
logo
Novo Integrated Sciences, Inc. (NVOS)
OTCMKTS · Delayed Price · Currency is USD
0.0021
-0.0009 (-30.00%)
At close: Dec 12, 2025

Novo Integrated Sciences Revenue

In the fiscal year ending August 31, 2024, Novo Integrated Sciences had annual revenue of $13.29M with 5.75% growth. Novo Integrated Sciences had revenue of $3.08M in the quarter ending August 31, 2024, a decrease of -6.74%.

Revenue
13.29M
Revenue Growth
+5.75%
P/S Ratio
0.00
Revenue / Employee
69.97K
Employees
264
Market Cap
41.43K

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 202413.29M722.34K5.75%
Aug 31, 202312.57M834.08K7.11%
Aug 31, 202211.74M2.43M26.14%
Aug 31, 20219.31M1.44M18.38%
Aug 31, 20207.86M-1.56M-16.57%
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro
Aug 31, 2016 Pro Pro Pro
Aug 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
American Oncology Network1.76B
Veradigm588.02M
Jushi Holdings260.43M
Glass House Brands196.17M
Elite Pharmaceuticals122.89M
Zomedica29.45M
Silence Therapeutics25.83M
Northwest Biotherapeutics937.00K
Revenue Rankings

Novo Integrated Sciences News

More News